22840-2479 NDC - ARIZONA GAMBEL OAK POLLEN (QUERCUS GAMBELII)

Drug Information

Product NDC: 22840-2479

Proprietary Name: Arizona Gambel Oak Pollen

Non Proprietary Name: Quercus gambelii

Active Ingredient(s):
  • .1 g/mL QUERCUS GAMBELII POLLEN


Administration Route(s): INTRADERMAL; PERCUTANEOUS; SUBCUTANEOUS

Dosage Form(s): SOLUTION

Pharmacy Class(es):
  • Allergens [CS];
  • Cell-mediated Immunity [PE];
  • Increased Histamine Release [PE];
  • Increased IgG Production [PE];
  • Non-Standardized Pollen Allergenic Extract [EPC];
  • Pollen [CS]

Labeler Information

Labeler Name: Greer Laboratories, Inc.
Product Type: NON-STANDARDIZED ALLERGENIC
FDA Application Number: BLA101833
Marketing Category: BLA
Start Marketing Date:9/15/1981

Package Information

No. Package Code Package Description Billing Unit
122840-2479-210 mL in 1 VIAL, MULTI-DOSE (22840-2479-2)
222840-2479-450 mL in 1 VIAL, MULTI-DOSE (22840-2479-4)

NDC Record

Field Name Field Value Definition
PRODUCT NDC22840-2479The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMENON-STANDARDIZED ALLERGENICIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEArizona Gambel Oak PollenIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
NON PROPRIETARY NAMEQuercus gambeliiThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMESOLUTIONThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
ROUTE NAMEINTRADERMAL; PERCUTANEOUS; SUBCUTANEOUSThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE9/15/1981The translation of the route code submitted by the firm, indicating route of administration.
MARKETING CATEGORY NAMEBLAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERBLA101833Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEGreer Laboratories, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEQUERCUS GAMBELII POLLENName of Company corresponding to the labeler code segment of the Product NDC.
ACTIVE NUMERATOR STRENGTH.1 
ACTIVE INGRED UNITg/mL 
PHARM CLASSESAllergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 4/12/2024